Overview and Scope
An animal model is a non-human species used in scientific research to understand biological processes, study disease mechanisms, and evaluate the efficacy and safety of new treatments and interventions. These models allow researchers to advance medical knowledge and develop new therapies, bridging the gap between basic research and clinical application.
Sizing and Forecast
The animal model market size has grown strongly in recent years. It will grow from $1.76 billion in 2023 to $1.92 billion in 2024 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to the rising adoption of animal models for biomedical research, surging expenditure and high investments in drug development and discovery, growing focus on precision medicine, and extensive applications of animal models in the healthcare industry.
The animal model market size is expected to see strong growth in the next few years. It will grow to $2.69 billion in 2028 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to advancements in genetic engineering, increased focus on personalized medicine, rising prevalence of chronic diseases, growing need for effective vaccines and therapeutics, increased investment in biomedical research. Major trends in the forecast period include increasing demand for animal models in drug discovery and development, rising prevalence of chronic diseases, physiological similarities between humans and animals reduces drug development time, growing consumption of personalized medicine driving the demand for humanized mice models, high growth of the market due to rising adoption of animal models for biomedical research.
Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/animal-model-global-market-report
Segmentation & Regional Insights
The animal model market covered in this report is segmented –
1) By Animal Type: Mice, Rat, Guinea Pigs, Rabbits, Hamsters, Other Animal Types
2) By Technology: Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Embryonic Stem Cell Injection, Nuclear Transfer, Other Technologies
3) By Application: Drug Discovery And Development, Basic Research, Other Applications
4) By End User: Research Institutes, Educational Institutes, Pharmaceutical Companies, Contract Research Organizations
Top 5 Major Players:
- Eurofins Scientific SE,
- Charles River Laboratories International Inc.,
- Pharmaron Beijing Co Ltd.,
- Inotiv Inc
- Biocytogen,
North America was the largest region in the animal model market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the animal model market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15510&type=smp
Major Driver Impacting Market Growth
The growing pharmaceutical research and development investment activities are expected to propel the growth of the animal model market going forward. Pharmaceutical research and development is a complex process where science and innovation converge to create medical advancements. With the rise of innovative therapies, pursuing treatments for complex diseases, alongwith driving scientific curiosity and commercial opportunities in the healthcare sector moves research and development process. Animal models are crucial in pharmaceutical research and development for predicting drug efficacy, safety, and toxicity, providing insights into biological mechanisms, and aiding in developing new treatments by mimicking human physiological responses and disease progression in controlled settings. For instance, in June 2023, according to the European Federation of Pharmaceutical Industries and Associations, a Belgium-based trade association and lobbying organization, spending on pharmaceutical research and development across Europe was €44,500 ($47999) in 2022 and €42,533 million ($45877 million) in 2021, an increase of 7.82% from €39,442 ($42543 million) in 2020. Therefore, the growing pharmaceutical research and development investment is driving the animal model market.
Key Industry Players
Major companies operating in the animal model market are Eurofins Scientific SE, Charles River Laboratories International Inc., Pharmaron Beijing Co Ltd, Inotiv Inc., Biocytogen, Taconic Biosciences Incorporation, Cyagen Biosciences, Trans Genic Incorporation, Crown Bioscience Incorporation, Harbor BioMed, PharmaLegacy, PsychoGenics, Biomere Biomedical Research Models Inc., Genoway S.A, Alloy Therapeutics, Janvier Labs, Hera Biolabs, Ozgene Pty Ltd, Transposagen Biopharmaceuticals Inc., KMT Hepatech Inc., AniLocus Inc., BioXpert, Harlan Sprague Dawley Inc.
The animal model market report table of contents includes:
1. Executive Summary
2. Animal Model Market Characteristics
3. Animal Model Market Trends And Strategies
4. Animal Model Market – Macro Economic Scenario
5. Global Animal Model Market Size and Growth
….
32. Global Animal Model Market Competitive Benchmarking
33. Global Animal Model Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Animal Model Market
35. Animal Model Market Future Outlook and Potential Analysis
36. Appendix
List Of Tables:
Table 1: Global Historic Market Growth, 2018-2023, $ Billion
Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
Table 3: Global Animal Model Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 4: Global Animal Model Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 5: Global Animal Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
….
Table 75: Eurofins Scientific SE Financial Performance
Table 76: Charles River Laboratories International Inc. Financial Performance
Table 77: Pharmaron Beijing Co Ltd Financial Performance
Table 78: Inotiv Inc. Financial Performance
Table 79: Biocytogen Financial Performance
Explore the trending research reports from TBRC:
https://topprnews.com/last-mile-delivery-market-growth/
https://topprnews.com/nuts-market-growth/
https://topprnews.com/pharma-and-biotech-crm-software-market-size/
https://goodprnews.com/last-mile-delivery-market-growth/
https://goodprnews.com/nuts-market-growth/
https://goodprnews.com/pharma-and-biotech-crm-software-market-size/
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
